Faster TB shield for transplant patients?
NCT ID NCT05411744
Summary
This study is testing a shorter, 1-month treatment to prevent latent tuberculosis (TB) from becoming active in people waiting for a kidney transplant. Researchers want to see if this shorter regimen is safe, if patients can complete it, and how the body processes the drugs. The goal is to find a more manageable way to protect these high-risk patients from developing full-blown TB after their transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pinki J Bhatt
New Brunswick, New Jersey, 08901, United States
Conditions
Explore the condition pages connected to this study.